Abdullah ÜLKÜ, ORÇUN YALAV, AHMET GÖKHAN SARITAŞ, Ahmet RENCÜZOĞULLARI, Kubilay DALCI, İsmail Cem ERAY, Özgür YAĞMUR, Atılgan Tolga AKCAM

Long-term Outcomes of Surgical Management of Insulinoma: Single Center Experience

Objective: Limited data are available in regards to the surgical management and outcomes of insulinoma. This study aimed to assess the outcomes associated with surgical treatment of insulinoma, as the most common pancreatic endocrine tumor Methods: Medical records of patients who diagnosed as insulinoma from 2000 to 2010 at General Surgery Department of Cukurova University Hospital were retrospectively reviewed. Surgical treatment (resection vs. enucleation) was based on preoperative radiological investigations (abdominal spiral contrast tomography, ultrasound, selective angiography for selected cases) and intra-operative ultrasound imaging once indicated. Conclusion: Surgical treatment of insulinoma is associated with favorable outcomes.Intra-operative ultrasound with manual palpation is still the gold standard for localizing insulinoma. Location, size and relationship with main pancreatic duct of the lesions are key components for the selection of optimal surgical procedure.

İnsülinomanin Cerrahi Yönetiminde Uzun Dönem Sonuçlar: Tek Merkez Deneyimi

Giriş: İnsülinomanin cerrahi yönetimi ve sonuçlarıyla ilişkili olarak sınırlı miktarda bilgiler mevcuttur.Bu çalısma en sık pankreatik endokrin tümör olan insülinomaların cerrahi tedavisiyle ilgili sonuçları değerlendirmeyi amaçlamıştır Yöntemler: Çukurova Üniverstitesi Genel Cerrahi Departmanında 2000 ile 2010 yılları arasında insulinoma tanısıyla ameliyat edilen hastalar geriye dönük olarak değerlendirildi. Rezeksiyon yada enükleasyondan oluşan cerrahi tedavi kararı preoperatif radyolojik değerlendirme (abdominalkontrastlı tomografi, ultrason ve endikasyou olan hastaraselektifanjiografi) ve intraoperatifultrasonografik görüntülemeye göre yapıldı. Bulgular: Cerrahi olarak tedavi edilen, insulinoma tanısı alan ve ortalama takip süresi 5.3 yıl (0.5-10) olan 13 hasta (K/E:9/4) calışmayadahil edildi. Enükleasyon 11 hastaya uygulanırken 2 hastaya distalpankreatektomi (biri dalak koruycu) uygulandı. Mortalite izlenmedi. Cerrahi sonrası tüm hastalar tekrar ameliyat gereksinimi olmaksızın kabul edilebilir komplikasyon oranları (panreatik fistül, n=3; pankreatit, n=1) ile normoglisemik hale geldi. Sonuç: İnsülinomanin cerrahi tedavisi olumlu klinik sonuçlarla ilişkilidir. İnsulinomanin lokalizasyonunu saptamada intraoperatifultrasonla birlikte palpasyonla yapılan değerlendirme altın standarda sahiptir. Uygun cerrahi prosedürü belirlemede lezyonun lokalizasyonu, boyutu ve ana pankreatik kanal ile ilişkisi kritik öneme sahiptir.

PDF

___

Kulke MH, Anthony LB, Bushnell DL et al .Nanetstreatment guidelines: well-differentiatedneuroendocrine tumors of the stomach andpancreas.Pancreas .2010; 39: 735-752.

La Rosa S, Pariani D, Calandra Cet al. Ectopicduodenal insulinoma: a very rare and challengingtumor type. Description of a case and review of theliterature.EndocrPathol. 2013; 24: 213-9

Thompson SM, Vella A, Thompson GB et al. SelectiveArterial Calcium Stimulation With Hepatic VenousSampling Differentiates Insulinoma FromNesidioblastosis. J ClinEndocrinolMetab. 2015; 100:4189-97

Nikfarjam M, Warshaw AL, Axelrod L et al. Improvedcontemporary surgical management of insulinomas: a25-year experience at the Massachusetts GeneralHospital. Ann Surg .2008; 247: 165-72

Gouya H, Vignaux O, Augui J et al. CT, endoscopicsonography, and a combined protocol for preoperativeevaluation of pancreatic insulinomas. AJR Am JRoentgenol. 2003; 181: 987-92

Halfdanarson TR, Rabe KG, Rubin J et al. Pancreaticneuroendocrine tumors (PNETs): incidence, prognosisand recent trend toward improved survival. Ann Onc.2008; 19: 1727-33.

Tamm EP, Bhosale P, Lee JH et al .State of-the-artimaging of pancreatic neuroendocrine tumors.SurgOncolClin N Am .2016;25: 375-400.

Zhang T, Mu Y, Qu Letal.Accurate combinedpreoperative localization of insulinomas aid the choicefor enucleation: a single institution experience over25years. Hepatogastroenterology. 2012; 59: 1282-5.

Mehrabi A, Fischer L, Hafezi Met al. A systematicreview of localization, surgical treatment options, andoutcome of insulinoma. Pancreas .2014; 43: 675-86.

Joseph AJ, Kapoor N, Simon EG etal.Endoscopicultrasonography-a sensitive tool in the preoperativelocalization of insulinoma. Endocr Pract.2013; 19: 602-8

An L, Li W, Yao KC et al. Assessment of contrastenhanced ultrasonography in diagnosis andpreoperative localization of insulinoma. Eur JRadiol.2011;80: 675-80

Guo Q, Wu Y. Surgical treatment of pancreatic isletcell tumor:report of 44 cases.Hepatogastroenterology.2013; 60: 2099-102

Okabayashi T, Shima Y, Sumiyoshi Tet al. Diagnosisand management of insulinoma. World JGastroenterol.2013; 19: 829-37.

Puli SR, Kalva N, Bechtold MLet al, Diagnosticaccuracy of endoscopic ultrasound in pancreaticneuroendocrine tumors: a systematic review andmetaanalysis. World J Gastroenterol.2013; 19: 3678-84.

Tellez-Avila FI, Acosta-Villavicencio GY, Chan Cet al.Diagnostic yield of endoscopic ultrasound in patientswith hypoglicemia and insulinomasuspected.EndoscUltrasound.2015; 4: 52-5.

Jensen RT, Cadiot G, Brandi ML et al. ENETS ConsensusGuidelines for the management of patients withdigestive neuroendocrine neoplasms: functionalpancreatic endocrine tumor syndromes.Neuroendocrinology. 2012; 95: 98-119.

ChrysanthiA , Alexander M. N. , Ioannis K. etal.Laparoscopic surgery for pancreatic insulinomas: anupdateHormones.2016; 15: 157-69.

Reddy MR, Ramakrishnan S, Kalra P et al. Chronicprogressive encephalopathy,intractable seizures, andneuropathy: A triad of neurological features ininsulinoma. Neurol India .2012; 60: 238-9.

Ito T, Igarashi H, Jensen RT.Pancreatic neuroendocrinetumors: clinical features, diagnosis and medicaltreatment: advances. Best Pract Res ClinGastroenterol.2012; 26: 737-53.

Elliso TA, Edil BH .The current management ofpancreatic neuroendocrine tumors. Adv Surg.2012; 46:283-96

Krampiz, GW. , Norton JA.Pancreatic neuroendocrinetumors. CurrProbl Surg. 2013; 50:509–45.

Chiruvlla A, Kooby DA. Surgical management ofpancreatic neuroendocrine tumors. SurgOncolClin NAm . 2016;25:401–21

deHerder WW, vanSchaik E, Kwekkeboom D et al. Newtherapeutic options for metastatic malignantinsulinomas. ClinEndocrinol (Oxf). 2011; 75: 277-84